Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Return on Assets (2016 - 2025)

Gyre Therapeutics (GYRE) has disclosed Return on Assets for 15 consecutive years, with 0.09% as the latest value for Q4 2025.

  • Quarterly Return on Assets rose 13.0% to 0.09% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.09% through Dec 2025, up 13.0% year-over-year, with the annual reading at 0.1% for FY2025, 15.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.09% at Gyre Therapeutics, up from 0.07% in the prior quarter.
  • The five-year high for Return on Assets was 0.43% in Q1 2023, with the low at 1.67% in Q1 2022.
  • Average Return on Assets over 5 years is 0.56%, with a median of 0.66% recorded in 2024.
  • Peak annual rise in Return on Assets hit 210bps in 2023, while the deepest fall reached -151bps in 2023.
  • Over 5 years, Return on Assets stood at 1.31% in 2021, then surged by 105bps to 0.06% in 2022, then crashed by -2385bps to 1.35% in 2023, then soared by 97bps to 0.04% in 2024, then surged by 327bps to 0.09% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.09%, 0.07%, and 0.1% for Q4 2025, Q3 2025, and Q2 2025 respectively.